Home » Mylan Receives Approval for Generic Accuretic
Mylan Receives Approval for Generic Accuretic
The FDA has approved Mylan Pharmaceuticals' abbreviated new drug application for quinapril HCl and hydrochlorothiazide tablets in 10-mg/12.5-mg, 20-mg/12.5-mg and 20-mg/25-mg strengths.
Mylan's drug is the generic equivalent of Pfizer's Accuretic tablets, which are indicated to treat high blood pressure. Pfizer's Accuretic and Accupril had combined sales of approximately $665 million in 2004. The company does not individually list sales of its blood pressure drugs.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
02May
-
07May
-
14May
-
23May
-
30May